Tumor angiogenesis can be blocked by the miR-200 family members via targeting the VEGF signaling pathway components, such as VEGF-A, FLT1/VEGFR1, and KDR/VEGFR2 [49]. This evidence concerns the gene FLT1 and neoplasm.